Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.
Our goal is to address the many scientific, social, and policy challenges in the totality of delivering an effective COVID-19 vaccine.
As of early April, statistics showed the vaccine breakdown between women and men was generally close to 60% and 40%.
The federal government has paused administration of the vaccine while it investigates a rare blood clotting disorder.
Funding can be used for partnerships with community-based organizations to increase vaccine uptake, including for underserved groups.
The Centers for Disease and Control Prevention recommends that fully vaccinated people can travel at low risk to themselves.
Research suggests protective effect of natural infection or vaccination is likely to be persistent.
Fewer people waiting to see how others respond to the vaccines before deciding to get vaccinated themselves.
A study involved health care personnel, first responders, and essential workers in six states.
My story illustrates how COVID-19 vaccine rollouts in Canada expose inequities. Then there’s the issue of vaccine selfies.
While the United States is getting closer to this point, most health experts caution, it still has ground to cover.
On April 15, full and free access to all virtual session recordings from the HIV and COVID-19 conference will be provided online.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
Leading cancer and infectious disease experts provide recommendations for both treatment and prevention of COVID-19 for people with cancer.
COVID-19 cases, hospitalizations and deaths continue to drop in the United States, but a global pandemic cannot be defeated in one country.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.